Novo Nordisk A/S
CSE:NOVO B
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NOVO B's stock price target?
Not Available
NOVO B doesn't have any price targets made by Wall Street professionals.
What is Novo Nordisk A/S's Revenue forecast?
Projected CAGR
16%
For the last 8 years the
compound annual growth rate for
Novo Nordisk A/S's revenue is
13%.
The projected
CAGR
for the next 3 years is
16%.
What is Novo Nordisk A/S's Operating Income forecast?
Projected CAGR
16%
For the last 8 years the
compound annual growth rate for
Novo Nordisk A/S's operating income is
14%.
The projected
CAGR
for the next 3 years is
16%.
What is Novo Nordisk A/S's Net Income forecast?
Projected CAGR
18%
For the last 8 years the
compound annual growth rate for
Novo Nordisk A/S's net income is
13%.
The projected
CAGR
for the next 3 years is
18%.
You don't have any saved screeners yet
